Cargando…
Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells
INTRODUCTION: The HIV protease inhibitor nelfinavir is currently under investigation as a new anti-cancer drug. Several studies have shown that nelfinavir induces cell cycle arrest, endoplasmic reticulum stress, autophagy, and apoptosis in cancer cells. In the present article, the effect of nelfinav...
Autores principales: | Brüning, Ansgar, Friese, Klaus, Burges, Alexander, Mylonas, Ioannis |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949632/ https://www.ncbi.nlm.nih.gov/pubmed/20594311 http://dx.doi.org/10.1186/bcr2602 |
Ejemplares similares
-
The mitochondria-independent cytotoxic effect of nelfinavir on leukemia cells can be enhanced by sorafenib-mediated mcl-1 downregulation and mitochondrial membrane destabilization
por: Brüning, Ansgar, et al.
Publicado: (2010) -
The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
por: Besse, Lenka, et al.
Publicado: (2023) -
Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells
por: Soprano, Maria, et al.
Publicado: (2016) -
Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?
por: Bassarak, Nina, et al.
Publicado: (2010) -
Nelfinavir and Nelfinavir Analogs Block Site-2 Protease Cleavage to Inhibit Castration-Resistant Prostate Cancer
por: Guan, Min, et al.
Publicado: (2015)